There is no FDA-approved cure or disease-modifying treatment for PSP. The drugs used to treat Alzheimer’s and Parkinson’s do not work. However, researchers and advocates are optimistic about new treatments. An upcoming platform trial will test three different treatments at once in Phase 2 trials, and Novartis will test its anti-tau drug in a Phase 3 trial.